Valuation Gilead Sciences, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 14:21:27 13/03/2026 GMT			5-day change	1st Jan Change
146.09 ^USD	+1.18%		+2.08%	+19.71%

03-11	Gilead Sciences, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:00 AM
03-10	Gilead Sciences, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 11:20 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	91,081	107,677	100,942	115,118	152,281	180,267	-	-
Change	-	18.22%	-6.25%	14.04%	32.28%	18.38%	-	-
Enterprise Value (EV) ¹	118,530	126,522	118,665	131,838	169,585	184,877	177,168	163,260
Change	-	6.74%	-6.21%	11.1%	28.63%	9.02%	-4.17%	-7.85%
P/E ratio	14.7x	23.6x	18x	243x	18.1x	20.1x	17.4x	16.4x
PBR	4.32x	5.05x	4.48x	5.98x	6.73x	6.82x	5.25x	4.42x
PEG	-	-0.9x	0.8x	-2.7x	0x	3.14x	1.1x	2.59x
Capitalization / Revenue	3.34x	3.95x	3.72x	4x	5.17x	5.97x	5.63x	5.37x
EV / Revenue	4.34x	4.64x	4.38x	4.59x	5.76x	6.12x	5.53x	4.86x
EV / EBITDA	8.12x	8.86x	9.01x	11.7x	10.6x	11.1x	9.97x	8.54x
EV / EBIT	9.45x	10.4x	11.3x	15.5x	12.9x	13x	11.4x	9.77x
EV / FCF	11x	15.2x	16x	12.8x	17.9x	14.6x	13.7x	12.3x
FCF Yield	9.12%	6.59%	6.25%	7.82%	5.58%	6.86%	7.3%	8.16%
Dividend per Share ²	2.84	2.92	3	3.08	3.16	3.256	3.608	2.826
Rate of return	3.91%	3.4%	3.7%	3.33%	2.57%	2.24%	2.48%	1.95%
EPS ²	4.93	3.64	4.5	0.38	6.78	7.214	8.33	8.857
Distribution rate	57.6%	80.2%	66.7%	811%	46.6%	45.1%	43.3%	31.9%
Net sales ¹	27,305	27,281	27,116	28,754	29,443	30,186	32,015	33,571
EBITDA ¹	14,598	14,283	13,177	11,287	15,953	16,688	17,771	19,109
EBIT ¹	12,548	12,180	10,484	8,520	13,193	14,183	15,586	16,702
Net income ¹	6,225	4,592	5,665	480	8,510	9,056	10,014	10,925
Net Debt ¹	27,449	18,845	17,723	16,720	17,304	4,611	-3,099	-17,007
Reference price ²	72.61	85.85	81.01	92.37	122.74	145.21	145.21	145.21
Nbr of stocks (in thousands)	1,254,384	1,254,244	1,246,042	1,246,266	1,240,680	1,241,421	-	-
Announcement Date	01/02/22	02/02/23	06/02/24	11/02/25	10/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GILEAD SCIENCES, INC.	20.13x	6.12x	11.08x	2.24%	180B
ELI LILLY AND COMPANY	28.72x	10.82x	21.74x	0.68%	873B
JOHNSON & JOHNSON	25.68x	5.98x	16.28x	2.19%	583B
ABBVIE INC.	24.62x	6.7x	13.46x	3.08%	398B
ROCHE HOLDING AG	17.19x	4.19x	10.36x	3.16%	324B
ASTRAZENECA PLC	24.12x	5.03x	13.93x	1.73%	297B
NOVARTIS AG	20.99x	5.66x	13.99x	2.86%	294B
MERCK & CO., INC.	27.09x	4.75x	14.85x	2.91%	287B
AMGEN INC.	24.74x	6.28x	11.18x	2.73%	198B
PFIZER INC.	12.57x	3.19x	7.6x	6.55%	153B
Average	22.58x	5.87x	13.45x	2.81%	358.81B
Weighted average by Cap.	24.25x	6.78x	15.35x	2.3%